SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-011361
Filing Date
2023-03-31
Accepted
2023-03-31 16:03:05
Documents
14
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ka-20230331.htm   iXBRL 8-K 61634
2 EX-99.1 ka-ex99_1.htm EX-99 172612
3 GRAPHIC img94373455_0.jpg GRAPHIC 10862
  Complete submission text file 0000950170-23-011361.txt   386224

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ka-20230331_lab.xml EX-101.LAB 17935
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ka-20230331_pre.xml EX-101.PRE 11113
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ka-20230331.xsd EX-101.SCH 2471
8 EXTRACTED XBRL INSTANCE DOCUMENT ka-20230331_htm.xml XML 4695
Mailing Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98109
Business Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98109 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 23787451
SIC: 2834 Pharmaceutical Preparations